Baker Ellis Asset Management LLC

Position in SNY — Sanofi

CIK 1365559 Vancouver, WA

Position in SNY

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$3,470,049

-$532,119 QoQ

Shares Held

81,342

-2.1% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#145

of 712 holders

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Baker Ellis Asset Management LLC holds $17,156,761 across 7 Drug Manufacturers - General names. SNY ranks #2 (20.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,547	$4,254,378
2	SNY	Sanofi This page	81,342	$3,470,049
3	JNJ	Johnson & Johnson	13,294	$3,376,277
4	NVS	Novartis AG	14,950	$2,342,964
5	MRK	Merck & Co., Inc.	14,988	$1,925,958
6	ABBV	AbbVie Inc.	6,083	$1,530,726
7	BMY	Bristol Myers Squibb Co	4,450	$256,409

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,470,049	81,342	-2.1%	Shares	Sole	2026-07-23
2026-03-31	$4,002,168	83,067	-0.5%	Shares	Sole	2026-04-17
2025-12-31	$4,045,295	83,477	-10.2%	Shares	Sole	2026-01-21
2025-09-30	$4,385,682	92,917	-3.0%	Shares	Sole	2025-10-23
2025-06-30	$4,627,808	95,794	+2.1%	Shares	Sole	2025-07-08
2025-03-31	$5,201,038	93,780	+7.9%	Shares	Sole	2025-04-15
2024-12-31	$4,191,572	86,908	-5.7%	Shares	Sole	2025-01-17
2024-09-30	$5,312,852	92,189	-0.5%	Shares	Sole	2024-10-15
2024-06-30	$4,494,989	92,642	-0.9%	Shares	Sole	2024-07-09
2024-03-31	$4,544,197	93,502	-2.3%	Shares	Sole	2024-04-17
2023-12-31	$4,759,260	95,702	-5.7%	Shares	Sole	2024-01-23
2023-09-30	$5,442,153	101,457	+0.8%	Shares	Sole	2023-10-24
2023-06-30	$5,427,029	100,687	+1.7%	Shares	Sole	2023-08-09
2023-03-31	$5,387,144	98,992	+3707.4%	Shares	Sole	2023-05-08
2020-06-30	$132,730	2,600	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.